Distribution agreement for Zesty with System C

RNS Number : 9173R
Induction Healthcare Group PLC
11 July 2022
 

Induction Healthcare Group PLC

("Induction", the "Company", or the "Group")

 

Distribution agreement for Induction Zesty with System C

 

Induction (AIM: INHC), a leading digital health platform driving transformation of healthcare systems worldwide, announces that it has signed a non-exclusive Software Reseller Agreement ('the Agreement') with System C Healthcare Limited ('System C'), a supplier of health and social care information technology systems and services , for the Induction Zesty product in the UK.

 

Induction Zesty is a digital patient engagement portal that enables end-to-end healthcare management. The portal's interface provides a fully automated process for patients to manage their hospital appointments, view their letters and clinical records, as well as provide data remotely via digital questionnaires from a smartphone. 

 

System C specialises in providing health and social care solutions across whole care communities. Their product portfolio includes the CareFlow EPR, an electronic patient record system ('EPR'), which is currently used in 30 NHS Trusts across the UK. As part of the agreement, System C will now actively sell Induction Zesty into its new and existing customers using CareFlow EPR. The non-exclusive agreement covers an initial three-year term with automatic 12 month renewals thereafter.

 

NHS Trusts are looking for solutions which require minimum procurement but provide maximum impact. System C is able to link information from multiple systems to integrate workflows between care settings and support multi-provider reporting and analysis. As a result of this agreement, the procurement of Induction Zesty will be easy and more accessible for NHS Trusts already using CareFlow EPR and a proven, effective solution for new customers.

 

This comes at a time of significant national focus and spending on digital transformation for NHS secondary care providers in England, which is outlined in the NHS Long Term Plan1. Digitisation, especially through EPRs, is even more important to help tackle the backlog of elective care appointments following COVID-19 and support NHS Trusts to meet the new Minimum Digital Foundations requirements. System C has committed to providing solutions to address all aspects of NHS Long Term Plan and with 500K unique users already, Induction Zesty is a secure solution to support the government-led drive for patient portals in all UK hospitals.

 

1 https://www.longtermplan.nhs.uk/

 

Induction CEO, James Balmain, said:  "We have a long-standing relationship with System C, one of the largest domestic suppliers of EPR software to the NHS, and it is a great step forward to be formally partnered with them under a value-added reseller agreement. Given System C's market share and their ability to reach customers efficiently via their direct sales force, we expect to see significant revenue generated via this partnership over the coming years.

 

"Together with our value-added reseller agreement with Cerner Corporation, we now have access to over 40% of Acute hospitals through reseller agreements. This agreement with System C acts as further material reinforcement of our strategy to partner with, and build on top of, the key underlying systems used by hospitals."

 

Guy Lucchi, Managing Director of Healthcare at System C, said: "We are very pleased to be partnering with Induction. The Zesty patient portal is a welcome addition to our integrated EPR offering which will empower patients to receive and view their clinical appointment bookings and letters as well as reschedule and cancel appointments within the portal, via a direct link to CareFlow EPR."

 

 

- ENDS-

 

ENQUIRIES

 

Induction

James Balmain, Chief Executive Officer

Via Walbrook PR Ltd: induction@walbrookpr.com

Guy Mitchell, Chief Financial Officer

 


 

Singer Capital Markets (Nominated Adviser and Broker)

+44 (0)20 7496 3000

Philip Davies / Kailey Aliyar

 


 

Walbrook PR Ltd 

+44 (0)20 7933 8780 or induction@walbrookpr.com

Alice Woodings / Paul McManus

Mob: +44 (0)7407 804 654 / +44 (0)7980 541 893

 

 

About Induction -   www.inductionhealthcare.com

 

Induction (AIM: INHC) Induction delivers a suite of software solutions through a single integrated platform that transforms care delivery. Our system-wide applications help healthcare providers and administrators to deliver care at any stage remotely as well as face-to-face - giving the communities they serve greater flexibility, control and ease of access . Purpose-built for integration with leading Electronic Medical Record (EMR) platforms, our products offer immediate stand-alone value that becomes even greater when integrated with pre-existing systems.

 

Used at scale by national and regional healthcare systems, as well non-health government services, our applications are relied upon by hundreds of thousands of clinicians and millions of patients across almost every hospital in the British Isles.  

 

About System C Healthcare Limited - www.systemc.com

 

System C is a British technology company that has been supporting the NHS and social care for almost forty years. The organisation is a leading supplier in acute EPRs with 30 NHS Trusts. We are also the number one supplier in child health, a pioneer in electronic observations with over 38 Trusts using our systems, the fastest growing supplier in social care with 60% of councils and the market leader in hospital pharmacy and medicines management where we support £5bn+ medications per year across 350+ hospitals. Plus, we are the national provider of the COVID and flu vaccination system, NIMS.

 

Our Care Alliance partner, Graphnet, is the number one supplier in shared care records holding data on over 20m citizens, the number one supplier in population health analytics with over 17.3m citizens covered and provides remote monitoring to over 50,000 citizens.




 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRFZGGNVRLGZZM
UK 100

Latest directors dealings